Gilead Sciences: Still Opportunity to Grow?

Bernstein’s Geoffrey Porges and team hosted Gilead Sciences (GILD) chief operating officer John Milligan, at Bernstein’s Strategic Decisions Conference this morning–and note that the company believes it can continue to grow without resorting to big acquisitions. They explain why: Bloomberg Will certainly be difficult to drive continued growth on such a large business, but management [...]